Scarica l'app Stockscreener
0.444
2.07%
0.009
Dopo l'orario di chiusura:
.43
-0.014
-3.15%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché IPA Giù?
Forum
Previsione
Frazionamento azionario
Immunoprecise Antibodies Ltd Borsa (IPA) Ultime notizie
What is going on with ImmunoPrecise Antibodies Ltd? Sentiment Analysis - uspostnews.com
Will ImmunoPrecise Antibodies (NASDAQ:IPA) Spend Its Cash Wisely? - simplywall.st
H.C. Wainwright sets $50 target for ImmunoPrecise stock - Investing.com Australia
H.C. Wainwright sets $50 target for ImmunoPrecise stock By Investing.com - Investing.com South Africa
ImmunoPrecise Antibodies’ (IPA) “Buy” Rating Reiterated at HC Wainwright - Defense World
ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI- - GuruFocus
ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods - 01net
ImmunoPrecise Antibodies Aligns with FDA’s Move to Non-Animal Testing - TipRanks
ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSaitm with FDA's Shift to Non-Animal Testing Methods - Lelezard
AI Breakthrough: How IPA's LENSai Platform Leads FDA's Historic Shift from Animal Testing - Stock Titan
ImmunoPrecise Antibodies Partners with RIBOPRO to Enhance Antibody Discovery - TipRanks
HC Wainwright Has Positive Outlook of IPA FY2025 Earnings - Defense World
ImmunoPrecise Antibodies (IPA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
HC Wainwright Has Bearish Forecast for IPA FY2028 Earnings - Defense World
ImmunoPrecise Antibodies’ (IPA) “Speculative Buy” Rating Reaffirmed at Benchmark - Defense World
Benchmark maintains Speculative Buy on Immunoprecise stock By Investing.com - Investing.com Australia
Benchmark maintains Speculative Buy on Immunoprecise stock - Investing.com
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2025 Earnings Call Transcript - Insider Monkey
ImmunoPrecise Antibodies (NASDAQ:IPA) Price Target Lowered to $5.00 at HC Wainwright - Defense World
ImmunoPrecise Antibodies Earnings Call Highlights Growth - TipRanks
Immunoprecise stock target cut to $5 by H.C. Wainwright - Investing.com Australia
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Misses Revenue Estimates - MSN
ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ... By GuruFocus - Investing.com Canada
ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ... - Yahoo
ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlig - GuruFocus
ImmunoPrecise Antibodies Third Quarter 2025 Earnings: CA$0.66 loss per share (vs CA$0.11 loss in 3Q 2024) - Yahoo
ImmunoPrecise Antibodies Reports Q3 FY25 Financial Results - TipRanks
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 - 01net
Immunoprecise Antibodies Ltd reports results for the quarter ended January 31Earnings Summary - TradingView
Immunoprecise Antibodies (IPA) Reports Financial Results And Recent Business Highlights For Third Quarter Fiscal Year 2025 - MarketScreener
IMMUNOPRECISE ANTIBODIES Earnings Results: $IPA Reports Quarterly Earnings - Nasdaq
ImmunoPrecise Secures Game-Changing $10M Deal as AI Division Reports 132% Growth - Stock Titan
A Look Ahead: ImmunoPrecise Antibodies's Earnings Forecast - Benzinga
IMMUNOPRECISE ANTIBODIES Earnings Preview: Recent $IPA Insider Trading, Hedge Fund Activity, and More - Nasdaq
Immunoprecise Antibodies Ltd expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Mason Hill Advisors buying at Ascot Resources (AOT) - The Globe and Mail
ImmunoPrecise Antibodies (IPA) to Release Quarterly Earnings on Friday - Defense World
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates - MSN
ImmunoPrecise Antibodies’ (IPA) Buy Rating Reiterated at HC Wainwright - Defense World
ImmunoPrecise partners for cancer drug advancement By Investing.com - Investing.com Australia
What's Going On With ImmunoPrecise Stock Thursday?ImmunoPrecise Antibodies (NASDAQ:IPA) - Benzinga
ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics. - 01Net
Sector Update: Health Care -March 13, 2025 at 08:52 am EDT - Marketscreener.com
ImmunoPrecise Antibodies Signs Partnership Deal to Develop Cancer Treatments -March 13, 2025 at 07:55 am EDT - Marketscreener.com
ImmunoPrecise Antibodies Partners for $10M Cancer Therapeutics Development - TipRanks
Positive Signs As Multiple Insiders Buy ImmunoPrecise Antibodies Stock - Yahoo Finance
ImmunoPrecise partners for cancer drug advancement - Investing.com
0.69%
21.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):